Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer

This is a schematic model showing surface and chemical structure of nanodiamond (ND) and Epirubicin (Epi), synthesis and aggregation of Epirubicin-ND complex (EPND). ND represented in truncated octahedron structure with different surface charge denoted with color. ND surface functional group indicated, including benzene ring, carboxyl group and hydrogen group. Molecular skeleton representing carbon, oxygen and Nitrogen atoms in Epi molecule was shown in red.
CREDIT: National University of Singapore
This is a schematic model showing surface and chemical structure of nanodiamond (ND) and Epirubicin (Epi), synthesis and aggregation of Epirubicin-ND complex (EPND). ND represented in truncated octahedron structure with different surface charge denoted with color. ND surface functional group indicated, including benzene ring, carboxyl group and hydrogen group. Molecular skeleton representing carbon, oxygen and Nitrogen atoms in Epi molecule was shown in red.

CREDIT: National University of Singapore

Abstract:
A study led by the National University of Singapore (NUS) found that attaching chemotherapy drug Epirubicin to nanodiamonds effectively eliminates chemoresistant cancer stem cells. The findings were first published online in ACS Nano, the official journal of the American Chemical Society, in December 2014.

Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer

Singapore | Posted on January 26th, 2015

The research team, led by Assistant Professor Edward Chow, Junior Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore) at NUS, demonstrated the use of nanotechnology to repurpose existing chemotherapy drugs as effective agents against chemoresistant cancer stem cells. Chemoresistance, which is the ability of cancer cells to escape chemotherapy treatment, is a primary cause of treatment failure in cancer. Cancer stem cells, a type of cancer cell which initiates the formation of tumours, are commonly found to be more resistant to chemotherapy than the rest of the bulk tumour, which can lead to cancer recurrence following chemotherapy treatment. As such, there is intense interest in developing new drugs or treatment strategies that overcome chemoresistance, particularly in cancer stem cells.

In this study, widely-used chemotherapy drug Epirubicin was attached to nanodiamonds, carbon structures with a diameter of about five nanometres, to develop a nanodiamond-Epirubicin drug delivery complex (EPND). The researchers found that while both standard Epirubicin as well as EPND were capable of killing normal cancer cells, only EPND was capable of killing chemoresistant cancer stem cells and preventing secondary tumour formation in xenograft models of liver cancer.

Compared to other approaches such as combinatorial therapy of chemotherapy drugs with inhibitors of chemoresistance pathways, delivery of existing chemotherapy drugs with nanomaterials, in this case nanodiamonds, provide a broader range of protection in a package that is both safer and more effective. The study showed that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage. As such, delivery of chemotherapy drugs by nanodiamonds not only enables enhanced killing of chemoresistant cancer stem cells, but may be a useful alternative for patients who cannot tolerate the toxic side effects of standard chemotherapy drugs.

Furthermore, the versatility of the nanodiamond-based drug delivery platform opens up the possibility of future applications of nanodiamonds such as the addition of other similar drugs as well as active targeting components such as antibodies or peptides against tumour cell surface proteins for targeted drug release. In addition, the application of a nanodiamond-drug delivery system is not limited to liver cancer. It offers a promising approach to treating a broad range of difficult cancers, particularly those driven by chemoresistant cancer stem cells.

In collaboration with Professor Dean Ho at the University of California Los Angeles and Professor Li Jianzhong at Peking University, Asst Prof Chow's group is working towards completing preclinical work on anthracycline delivery by nanodiamonds and hope to begin clinical trials in the near future.

####

For more information, please click here

Contacts:
Kimberley Wang

Copyright © National University of Singapore

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Cancer

One of the causes of aggressive liver cancer discovered: a 'molecular staple' that helps repair broken: DNA Researchers describe a new DNA repair mechanism that hinders cancer treatment January 27th, 2023

News and information

Stability of perovskite solar cells reaches next milestone January 27th, 2023

Qubits on strong stimulants: Researchers find ways to improve the storage time of quantum information in a spin rich material January 27th, 2023

UCF researcher receives Samsung International Global Research Outreach Award: The award from the multinational electronics corporation will fund the development of infrared night vision and thermal sensing camera technology for cell phones and consumer electronics January 27th, 2023

Temperature-sensing building material changes color to save energy January 27th, 2023

Nanomedicine

One of the causes of aggressive liver cancer discovered: a 'molecular staple' that helps repair broken: DNA Researchers describe a new DNA repair mechanism that hinders cancer treatment January 27th, 2023

New nanoparticles deliver therapy brain-wide, edit Alzheimer’s gene in mice: UW researchers have found a way to move gene therapies through the blood-brain barrier, a crucial step for brain-wide CRISPR treatments of disorders like Alzheimer's and Parkinson's disease January 20th, 2023

Team undertakes study of two-dimensional transition metal chalcogenides Important biomedical application, including biosensing December 9th, 2022

SLAC/Stanford researchers discover how a nano-chamber in the cell directs protein folding: The results challenge a 70-year-old theory of how proteins fold in our cells and have profound implications for treating diseases linked to protein misfolding December 9th, 2022

Discoveries

One of the causes of aggressive liver cancer discovered: a 'molecular staple' that helps repair broken: DNA Researchers describe a new DNA repair mechanism that hinders cancer treatment January 27th, 2023

Stability of perovskite solar cells reaches next milestone January 27th, 2023

Qubits on strong stimulants: Researchers find ways to improve the storage time of quantum information in a spin rich material January 27th, 2023

Temperature-sensing building material changes color to save energy January 27th, 2023

Announcements

UCF researcher receives Samsung International Global Research Outreach Award: The award from the multinational electronics corporation will fund the development of infrared night vision and thermal sensing camera technology for cell phones and consumer electronics January 27th, 2023

Temperature-sensing building material changes color to save energy January 27th, 2023

Quantum sensors see Weyl photocurrents flow: Boston College-led team develops new quantum sensor technique to image and understand the origin of photocurrent flow in Weyl semimetals January 27th, 2023

Department of Energy announces $9.1 million for research on quantum information science and nuclear physics: Projects span the development of quantum computing, algorithms, simulators, superconducting qubits, and quantum sensors for advancing nuclear physics January 27th, 2023

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Qubits on strong stimulants: Researchers find ways to improve the storage time of quantum information in a spin rich material January 27th, 2023

Temperature-sensing building material changes color to save energy January 27th, 2023

Quantum sensors see Weyl photocurrents flow: Boston College-led team develops new quantum sensor technique to image and understand the origin of photocurrent flow in Weyl semimetals January 27th, 2023

Danish quantum physicists make nanoscopic advance of colossal significance January 27th, 2023

Research partnerships

Polymer p-doping improves perovskite solar cell stability January 20th, 2023

SLAC/Stanford researchers discover how a nano-chamber in the cell directs protein folding: The results challenge a 70-year-old theory of how proteins fold in our cells and have profound implications for treating diseases linked to protein misfolding December 9th, 2022

New insights into energy loss open doors for one up-and-coming solar tech November 18th, 2022

New hybrid structures could pave the way to more stable quantum computers: Study shows that merging a topological insulator with a monolayer superconductor could support theorized topological superconductivity October 28th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project